MOGAD is associated with a unique pattern of volumetric brain changes, study suggests

Changes in brain volume in patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD) differentiate it from multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), new data suggest.